Sanofi and Regeneron announce approval of Kevzara® (sarilumab) to treat adult patients with moderately to severely active rheumatoid arthritis in the European Union

29th June 2017 Uncategorised 0

Sanofi

More: Sanofi and Regeneron announce approval of Kevzara® (sarilumab) to treat adult patients with moderately to severely active rheumatoid arthritis in the European Union
Source: MDlinx